Benign neoplasm of thyroid gland – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Tue, 02 Jun 2026 04:14:02 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Benign neoplasm of thyroid gland – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study Comparing Radiofrequency Ablation and Sodium Iodide (131I) for Treating Hyperthyroidism in Patients with Overactive Thyroid Nodules https://clinicaltrials.eu/trial/study-comparing-radiofrequency-ablation-and-sodium-iodide-131i-for-treating-hyperthyroidism-in-patients-with-overactive-thyroid-nodules/ Wed, 29 Apr 2026 15:03:42 +0000 https://clinicaltrials.eu/trial/study-comparing-radiofrequency-ablation-and-sodium-iodide-131i-for-treating-hyperthyroidism-in-patients-with-overactive-thyroid-nodules/ This clinical trial is focused on studying the treatment of hyperthyroidism caused by solitary autonomous thyroid nodules. Hyperthyroidism is a condition where the thyroid gland is overactive, producing too much thyroid hormone. The study compares two treatments: ultrasound-guided radiofrequency ablation and radioactive iodine therapy. Radioactive iodine, also known as sodium iodide (131I), is a chemical substance used to treat hyperthyroidism by reducing the activity of the thyroid gland.

The purpose of the study is to compare the effects of these treatments over one year, particularly looking at the occurrence of a condition called irreversible hypothyroidism, where the thyroid becomes underactive. Participants will receive either the radiofrequency ablation or the radioactive iodine treatment. The study will monitor various health outcomes, including thyroid function, nodule size, and quality of life, at different intervals over the course of a year.

Throughout the study, participants will undergo regular check-ups to assess their thyroid function and overall health. The study aims to provide valuable information on the effectiveness and safety of these treatments for managing hyperthyroidism caused by solitary thyroid nodules. This research could help improve treatment options and outcomes for individuals with this condition.

]]>